Oriental AromaticsQ2 FY25

Oriental Aromatics Q2 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹445.45P/E: 144.6Market Cap: ₹1.5K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • The company expects steady growth across all three verticals—fragrance and flavor, speciality aroma ingredients, and camphor—with the fragrance and flavor division growing through new customer acquisitions and product launches.
  • Hydrogenation plant at Vadodara is operating at about 30% capacity; onboarding of RFQ customers is expected in H2 FY25, which will support top-line growth.
  • Greenfield facility in Mahad commenced production in November 2024, focusing on specialty aroma ingredient Evermoss, expected to generate significant revenues—projected 160 to 200 crores from this molecule alone.
  • Combined expansions (Vadodara hydrogenation, Mahad Greenfield, process reengineering) may contribute an additional ₹250-300 crores in top line over the next 2-3 years.
  • Overall, growth of 5-10% is anticipated in existing businesses in H2 FY25, though camphor remains seasonal and demand will be monitored.
  • The company aims for a cautious but positive outlook in demand and revenue growth through product portfolio expansion and market penetration.

See what Oriental Aromatics management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no specific mention of any current or planned fundraising through debt or equity in the transcript.
  • The company reported a net debt-to-equity ratio of 0.35 as of 30 September 2024, indicating a moderate debt level.
  • Discussions in the call focused on operational performance, expansions, and new product launches without reference to raising funds.
  • The company appears to be financing ongoing expansions like the Mahad Greenfield project and Vadodara hydrogenation plant from existing resources.
  • If there are any developments related to fundraising, the management stated they would inform the investor community accordingly.

See what Oriental Aromatics management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Commercial production started at the Greenfield site in Mahad, Maharashtra, in November 2024, dedicated to producing a specialty aroma ingredient called Evermoss.
  • Investment at Mahad includes substantial plot development and infrastructure, with around 50-55% of costs toward the plot and utility block; approximately ₹70-75 crores directly invested in the product.
  • Hydrogenation plant at Vadodara commissioned in July 2024, currently operating at about 30% capacity; onboarding of RFQ customers expected in H2 2025.
  • Future expansions beyond the current announced phase at Mahad are not decided yet; the company will update investors as applicable.
  • Total revenue from expansions (Vadodara hydrogenation, Mahad, process reengineering) expected to add ₹250-300 crores in the next 2-3 years.
  • Depreciation from the Mahad plant estimated at ₹5-6 crores per year from Q4 FY25.

Track Oriental Aromatics — get its next earnings analysis in your feed

How does Oriental Aromatics rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisOriental Aromatics
Rev 3Mar 3

How does Oriental Aromatics rank in Chemicals & Petrochemicals?

Compare Oriental Aromatics against every Chemicals & Petrochemicals company (Q2 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →